It’s the last leg of what looks like an end-of-month rally as investors try to make the most of August’s losses. Traders are neck-deep into a data-heavy week from company fiscal reports that could chart the hike path for interest rates. ...
Jonathon Brown
|
August 31, 2023
|
It’s been dubbed the Age of Anxiety. Yet it’s quickly becoming far worse than that. With the arrival of globalism, the new millennium has already become synonymous with the threat of deadly pandemics. And the onslaught of the worst of them s...
Marc Davis
|
January 20, 2021
|
It has the potential to be the next frontier in the psychedelics renaissance, and it represents an unprecedented opportunity to innovate a notable advancement in mental health therapy. In anecdotal studies, mescaline has shown promise in treating depression, anxiety, PTSD,...
Marc Davis
|
April 6, 2021
|
As the cannabis market has started to recover amidst the COVID-19 pandemic, investors are looking at where the market can grow. One leading candidate is cannabinoid production. THC, CBD, and other specific cannabinoids can be useful for a variety of treatments, includ...
Omri Wallach
|
June 9, 2020
|
(Click image to play podcast) Stockhouse investors who are dialed into the not-only nascent but now, pardon the pun, mushrooming psychedelics sector are likely familiar with a mental health and wellness company “centred on developing and supporting the safe, ev...
Dave Jackson
|
October 8, 2020
|
Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...
Richard (Rick) Mills
|
December 3, 2019
|
The electric vehicle (EV) revolution is now in full gear, but there still remains a few obstacles to get more buyers into the market – namely EV range anxiety or the fear that their car's battery will die on them mid-trip. Now, there’s a single-source soluti...
Dave Jackson
|
May 13, 2022
|
The historical action of the precious metals sector over the past few weeks has continued. The strong recovery in GDX, GDXJ, and Silver has potentially invalidated the technical breakdown that occurred during the crash. It appears to be a failed breakdown. Furthermor...
Jordan Roy-Byrne, CMT
|
March 30, 2020
|
(Image via Mind Medicine Inc.) To say 2020 was a challenging year is an understatement. From markets hitting unprecedented highs to the economic cratering in March due to the COVID-19 Coronavirus pandemic that put stocks across the board to the ultimat...
Stockhouse Editorial
|
December 16, 2020
|
When Stockhouse Editorial last caught up with Cybin Inc. ( NEO.CYBN , NYSE: CYBIN , Forum ) back in October, our audience learned about a leading biotechnology company focused on researching and progressing psychedelic therapeutics by utilizing proprietary drug discover...
Dave Jackson
|
January 31, 2022
|